STOK (STOK) Stock Price & Analysis
STOK (STOK) fell 0.60% to USD 29.81 as of September 8, 2026 at 04:59 UTC, according to Nexqual real-time market data.
STOK last closed at USD 29.81; the session ranged USD 29.15–29.91 on volume of 714,062 shares. Market capitalization is —, with a 52-week range of USD 20.32–40.22 (NMS). Source: Nexqual, September 8, 2026 at 04:59 UTC.
Key Statistics (as of September 8, 2026 at 04:59 UTC)
| Price | USD 29.81 |
|---|---|
| Change | ▼ 0.60% (down) |
| Previous Close | USD 29.81 |
| Open | USD 29.81 |
| Day Range | USD 29.15 – 29.91 |
| 52-Week Range | USD 20.32 – 40.22 |
| Volume | 714,062 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (STOK)
Nexqual's technical model rates STOK "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 04:59 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.1 (neutral) |
| vs SMA50 | Below (USD 31.16) |
| MACD | -0.16 (negative) |
From STOK's Latest SEC 10-K Filing (filed 2026-03-16)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALEC | Alector, Inc. | USD 2.46 | ▼ 9.56% |
| GOSS | Gossamer Bio, Inc. | USD 0.18 | ▲ 1.33% |
| PHAT | Phathom Pharmaceuticals, Inc. | USD 9.5 | ▲ 2.59% |
| SRRK | Scholar Rock Holding Corporatio | USD 55.33 | ▼ 1.37% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 14.97 | ▲ 0.2% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:59 UTC. This page is informational and not investment advice.